HIV Therapeutics Market Report

Global and Region HIV Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：211
  • REPORT CODE：GMM940862
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of HIV Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of HIV Therapeuticsmarket, defines the market attractiveness level of HIV Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of HIV Therapeutics industry, describes the types of HIV Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global HIV Therapeutics market and the development prospects and opportunities of HIV Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global HIV Therapeutics market in Chapter 13.

    By Player:

    • AbbVie

    • Johnson & Johnson

    • Gilead Sciences

    • Merck & Co

    • Cipla Limited

    • Teva Pharmaceutical Industries Ltd

    • ViiV Healthcare

    • Boehringer Ingelheim International GmbH

    • F Hoffmann-La Roche Ltd

    • Bristol-Myers Squibb

    By Type:

    • Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)

    • Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

    • Entry and Fusion Inhibitors

    • Protease Inhibitors (PIs)

    • Integrase Inhibitors

    • Coreceptor Antagonists

    By End-User:

    • Hospitals

    • Clinics

    • Labs

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 HIV Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 HIV Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 HIV Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 HIV Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise HIV Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global HIV Therapeutics Consumption (2017-2022)

    • 7.2 United States HIV Therapeutics Consumption (2017-2022)

    • 7.3 Europe HIV Therapeutics Consumption (2017-2022)

    • 7.4 China HIV Therapeutics Consumption (2017-2022)

    • 7.5 Japan HIV Therapeutics Consumption (2017-2022)

    • 7.6 India HIV Therapeutics Consumption (2017-2022)

    • 7.7 South Korea HIV Therapeutics Consumption (2017-2022)

    8 Region and Country-wise HIV Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global HIV Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States HIV Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe HIV Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China HIV Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan HIV Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India HIV Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea HIV Therapeutics Consumption Forecast (2022-2028)

    9 Global HIV Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global HIV Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Entry and Fusion Inhibitors Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Protease Inhibitors (PIs) Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Integrase Inhibitors Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Coreceptor Antagonists Consumption and Growth Rate (2017-2022)

    • 9.2 Global HIV Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Labs Consumption and Growth Rate (2017-2022)

    10 Global HIV Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global HIV Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Entry and Fusion Inhibitors Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Protease Inhibitors (PIs) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Integrase Inhibitors Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Coreceptor Antagonists Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global HIV Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Labs Consumption Forecast and Growth Rate (2022-2028)

    11 Global HIV Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global HIV Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global HIV Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 HIV Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global HIV Therapeutics Market Competitive Analysis

    • 14.1 AbbVie

      • 14.1.1 AbbVie Company Details

      • 14.1.2 AbbVie HIV Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 AbbVie HIV Therapeutics Product and Service

    • 14.2 Johnson & Johnson

      • 14.2.1 Johnson & Johnson Company Details

      • 14.2.2 Johnson & Johnson HIV Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Johnson & Johnson HIV Therapeutics Product and Service

    • 14.3 Gilead Sciences

      • 14.3.1 Gilead Sciences Company Details

      • 14.3.2 Gilead Sciences HIV Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Gilead Sciences HIV Therapeutics Product and Service

    • 14.4 Merck & Co

      • 14.4.1 Merck & Co Company Details

      • 14.4.2 Merck & Co HIV Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Merck & Co HIV Therapeutics Product and Service

    • 14.5 Cipla Limited

      • 14.5.1 Cipla Limited Company Details

      • 14.5.2 Cipla Limited HIV Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Cipla Limited HIV Therapeutics Product and Service

    • 14.6 Teva Pharmaceutical Industries Ltd

      • 14.6.1 Teva Pharmaceutical Industries Ltd Company Details

      • 14.6.2 Teva Pharmaceutical Industries Ltd HIV Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Teva Pharmaceutical Industries Ltd HIV Therapeutics Product and Service

    • 14.7 ViiV Healthcare

      • 14.7.1 ViiV Healthcare Company Details

      • 14.7.2 ViiV Healthcare HIV Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 ViiV Healthcare HIV Therapeutics Product and Service

    • 14.8 Boehringer Ingelheim International GmbH

      • 14.8.1 Boehringer Ingelheim International GmbH Company Details

      • 14.8.2 Boehringer Ingelheim International GmbH HIV Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Boehringer Ingelheim International GmbH HIV Therapeutics Product and Service

    • 14.9 F Hoffmann-La Roche Ltd

      • 14.9.1 F Hoffmann-La Roche Ltd Company Details

      • 14.9.2 F Hoffmann-La Roche Ltd HIV Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 F Hoffmann-La Roche Ltd HIV Therapeutics Product and Service

    • 14.10 Bristol-Myers Squibb

      • 14.10.1 Bristol-Myers Squibb Company Details

      • 14.10.2 Bristol-Myers Squibb HIV Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Bristol-Myers Squibb HIV Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of HIV Therapeutics

    • Figure HIV Therapeutics Picture

    • Table Global HIV Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global HIV Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global HIV Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global HIV Therapeutics Consumption by Country (2017-2022)

    • Figure United States HIV Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe HIV Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China HIV Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan HIV Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India HIV Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea HIV Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global HIV Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States HIV Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe HIV Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China HIV Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan HIV Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India HIV Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea HIV Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Consumption and Growth Rate (2017-2022)

    • Figure Global Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Consumption and Growth Rate (2017-2022)

    • Figure Global Entry and Fusion Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global Protease Inhibitors (PIs) Consumption and Growth Rate (2017-2022)

    • Figure Global Integrase Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global Coreceptor Antagonists Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Labs Consumption and Growth Rate (2017-2022)

    • Figure Global Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Entry and Fusion Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Protease Inhibitors (PIs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Integrase Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Coreceptor Antagonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Labs Consumption Forecast and Growth Rate (2022-2028)

    • Table Global HIV Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global HIV Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie HIV Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie HIV Therapeutics Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson HIV Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson HIV Therapeutics Product and Service

    • Table Gilead Sciences (Foundation Year, Company Profile and etc.)

    • Table Gilead Sciences HIV Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences HIV Therapeutics Product and Service

    • Table Merck & Co (Foundation Year, Company Profile and etc.)

    • Table Merck & Co HIV Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co HIV Therapeutics Product and Service

    • Table Cipla Limited (Foundation Year, Company Profile and etc.)

    • Table Cipla Limited HIV Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cipla Limited HIV Therapeutics Product and Service

    • Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries Ltd HIV Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Ltd HIV Therapeutics Product and Service

    • Table ViiV Healthcare (Foundation Year, Company Profile and etc.)

    • Table ViiV Healthcare HIV Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table ViiV Healthcare HIV Therapeutics Product and Service

    • Table Boehringer Ingelheim International GmbH (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim International GmbH HIV Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim International GmbH HIV Therapeutics Product and Service

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd HIV Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd HIV Therapeutics Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb HIV Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb HIV Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US